JIPOAd
PARP
ESID
  • Users Online: 350
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2019| January-March  | Volume 2 | Issue 1  
    Online since January 24, 2019

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL ARTICLE
The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa
Abdul Rahman Jazieh, Adda Bounedjar, Fouad Al Dayel, Shamayel Fahem, Arafat Tfayli, Kakil Rasul, Hassan Jaafar, Mohammad Jaloudi, Turki Al Fayea, Hatim Q Al Maghrabi, Hanaa Bamefleh, Khaled Al Kattan, Blaha Larbaoui, Taha Filali, Hamed Al Husaini, Yosra Ali, in collaboration with the Arab Collaborative Hematology Oncology Group (ACHOG)
January-March 2019, 2(1):4-7
DOI:10.4103/JIPO.JIPO_22_18  
  1,728 119 2
REVIEW ARTICLE
Extracellular signal-regulated kinase (ERK) inhibitors in oncology clinical trials
Haelee M Chin, David K Lai, Gerald S Falchook
January-March 2019, 2(1):10-16
DOI:10.4103/JIPO.JIPO_17_18  
  1,497 249 2
EDITORIAL
Optimizing Precision Oncology and Immunotherapy Strategies: Moving into the Next Stage of Cancer Medicine
Phoebe Lewis, Timothy A Yap
January-March 2019, 2(1):1-3
DOI:10.4103/JIPO.JIPO_26_18  
  1,291 210 -
COMMENTARY
Opening new boundaries in biomarker detection: Awakening of middle east and North Africa Region
Christian Rolfo, Umberto Malapelle
January-March 2019, 2(1):8-9
DOI:10.4103/JIPO.JIPO_27_18  
  832 97 -
SPECIAL ARTICLE
5th Annual immuno-oncology 360° conference: What to expect
Kate Woda
January-March 2019, 2(1):17-18
DOI:10.4103/2590-017X.249502  
  701 105 -